Clue Reaches 1 Million Paid Subscribers, Cementing Position as Leading Data-Driven Women’s Health Intelligence Platform

Article content

BERLIN, May 22, 2025 (GLOBE NEWSWIRE) — Clue, the data-driven women’s health intelligence platform, today announced it has reached 1 million paid subscribers, more than doubling its subscriber base in just over a year. This milestone comes amid explosive growth in the digital menstrual health market, projected to grow from €1.2 billion in 2024 to €9.3 billion by 2030 — an 8x increase in just six years.

Article content

Article content

As consumers increasingly seek digital tools to manage their health proactively, women are turning to technology for insights into their reproductive health. Recent studies show that 78% of women experience cycle-related symptoms that impact their quality of life, yet traditional healthcare systems often fail to address these concerns adequately.

Article content

Article content

“Reaching one million paid subscribers represents more than just a business milestone,” said Rhiannon White, CEO of Clue. “It validates our mission to provide women everywhere with deeply personalized, science-driven health intelligence that helps them understand and navigate their bodies with confidence. Our subscribers are using Clue not just to track periods, but to gain insights across their entire reproductive journey.”

Article content

Article content

Scientific Foundation and Regulatory Excellence Drive Trust

Article content

Central to Clue’s success has been its unwavering commitment to scientific rigor, medical accuracy, and data privacy. The company maintains the highest medical standards with CE-licensed conceive products and FDA compliance, ensuring both user trust and clinical validity. This regulatory excellence has enabled Clue to amass one of the world’s largest reproductive health dataset.

Article content

Clue’s remarkable longitudinal dataset comprises over 25 billion health data points, 750 million cycles analyzed, and 3.2 million confirmed diagnoses recorded. This rich data foundation, protected by stringent GDPR privacy measures, has earned the trust of more than 10 million women worldwide who confidently share their most sensitive health information with the platform.

Article content

Article content

Powerful Technology and Data Create Superior User Experience

Article content

By combining this extensive dataset with its technology platform, Clue delivers highly personalized reproductive lifecycle analytics that adapt to each user’s unique patterns over time. These include deep cycle intelligence, conception predictions, pregnancy tracking, and perimenopause support — comprehensive insights that evolve with women through every life stage.

Article content

This data-driven approach has resulted in exceptional user satisfaction, with Clue maintaining a 4.8-star rating from over 2.5 million reviews. The app’s subscriber retention rates are substantially above industry averages, with 81% of users reporting that Clue helps them feel more prepared for symptoms and 72% saying it gives them greater control of their health.

Article content

“Our users consistently tell us that Clue provides insights they can’t get elsewhere,” said White. “They’re not just tracking their periods — they’re understanding patterns in their energy levels, sleep quality, mood, and physical symptoms that impact their daily lives. This comprehensive understanding builds loyalty that translates directly to subscription longevity.”